Group 1 - The report indicates that Huaron Chemical Co., Ltd. has effectively established and implemented various internal regulations to prevent related party transactions and manage fundraising [1][2] - The company has not missed any deadlines for reviewing information disclosure documents, with zero instances of late reviews [1] - There have been no reported issues requiring attention, and the company has maintained compliance with regulatory requirements [2] Group 2 - All major contracts have been executed normally without any significant risks affecting their performance during the reporting period [2] - The sponsor has not faced any regulatory actions from the China Securities Regulatory Commission or the Shenzhen Stock Exchange during the reporting period [2]

华融化学股份有限公司 2025 年半年度报 告摘要 证券代码：301256 证券简称：华融化学 公告编号： 华融化学股份有限公司 2025 年半年度报告摘要 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监 会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 | 然人 | | | | | | | --- | --- | --- | --- | --- | --- | | 北京利 | | | | | | | 和制药 | 境内非 | | | | | | 国有法 | | 0.52% | 2,512,100 | 0 不适 | | | 用 | | | 0 | | | | 有限公 | | | | | | | 人 | | | | | | | 司 | | | | | | | 汇聚农 | | | | | | | 境内非 | | | | | | | 牧科技 | | | | | | | 国有法 | | 0.38% | 1,800,000 | 0 不适 | | | 用 | | | 0 | | | | 有限公 | | ...

Core Viewpoint - Huarong Chemical Co., Ltd. announced a mid-year profit distribution plan, proposing a cash dividend of 0.40 RMB per 10 shares, totaling 19.2 million RMB, based on a total share capital of 48 million shares [2][3]. Group 1: Profit Distribution Plan - The company will distribute a cash dividend of 0.40 RMB per 10 shares to all registered shareholders, amounting to a total of 19,200,000 RMB (including tax) [2][3]. - The profit distribution plan was approved in meetings held on August 11 and August 12, 2025, and does not require submission to the shareholders' meeting [2][3]. - As of June 30, 2025, the company's cumulative undistributed profits amounted to 307,929,235.21 RMB, with the parent company's undistributed profits at 130,716,599.24 RMB [2][3]. Group 2: Justification of Cash Dividend Plan - The profit distribution plan complies with relevant regulations, including the guidelines for cash dividends for listed companies and the company's future three-year shareholder return plan [3]. - The plan reflects the company's focus on long-term sustainable development and emphasizes reasonable returns for investors, considering external conditions and the company's profitability and cash flow [3]. - The distribution arrangement aligns with the company's profit distribution policy and future development plans, ensuring legality, compliance, and rationality [3].

华融化学股份有限公司（以下简称"公司"）第二届董事会第十三次会议通知于 望中鼎国际18楼会议室以现场结合通讯表决方式召开。应出席会议的董事有7名，实际 出席会议的董事有7名（其中，李建雄、张明贵、刘磊以通讯表决方式出席会议）。会 议由董事长邵军先生主持，公司监事、高级管理人员列席了本次会议。本次会议的召 集、召开和表决程序均符合《公司法》等相关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。会议表决方式为记名投票表决。 证券代码：301256 证券简称：华融化学 公告编号：2025-038 华融化学股份有限公司 第二届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 表决结果为：同意7票，反对0票，弃权0票。 本议案已事先经董事会独立董事专门会议审议通过。 全体董事一致认为，公司本次会计估计变更是基于公司业务发展实际情况进行的 调整，符合相关法律、法规、《企业会计准则》及《公司章程》的规定，变更后的会 计估计能够为投资者提供更可靠、更准确的会计信息，不存在损害公司及全体股东利 益的情形。因此，同意本 ...

证券时报·数据宝统计显示，公司今日公布了半年报，共实现营业收入7.70亿元，同比增长48.32%，实 现净利润3288.48万元，同比下降25.30%，基本每股收益为0.07元，加权平均净资产收益率为1.9%。 资金面上看，该股今日主力资金净流入255.11万元，近5日主力资金净流入5102.85万元。 两融数据显示，该股最新融资余额为9900.63万元，近5日增加1398.15万元，增幅为16.44%。 8月12日华融化学发布2025半年度分配预案，拟10派0.4元（含税），预计派现金额合计为1920.00万元。 派现额占净利润比例为58.39%，这是公司上市以来，累计第6次派现。 公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派0.4元（含税） | 0.19 | 0.34 | | 2024.12.31 | 10派1.2元（含税） | 0.58 | 1.56 | | 2024.06.30 | 10派0.5元（含税） | 0.24 | 0.71 | | 2023.12. ...

Core Viewpoint - Huarong Chemical (301256) reported a significant increase in revenue for the first half of 2025, but faced a decline in net profit compared to the previous year [1] Financial Performance - The company achieved an operating income of 770 million yuan, representing a year-on-year growth of 48.32% [1] - Net profit for the period was 32.8848 million yuan, which is a decrease of 25.30% year-on-year [1] - Basic earnings per share were reported at 0.07 yuan [1] - The weighted average return on equity (ROE) stood at 1.90% [1]

Group 1 - The core point of the article is that Huarong Chemical announced the approval of several proposals during the 12th meeting of its second supervisory board [2] Group 2 - The announcement includes the approval of the agenda and its summary [2]

证券日报网讯 8月12日晚间，华融化学发布公告称，公司第二届董事会第十三次会议审议通过了《关于 及其摘要的议案》等多项议案。 （文章来源：证券日报） ...

Core Viewpoint - Huarong Chemical (301256.SZ) reported a significant increase in revenue for the first half of 2025, but experienced a decline in net profit compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 770 million yuan, representing a year-on-year growth of 48.32% [1] - The net profit attributable to shareholders of the listed company was 32.8848 million yuan, showing a year-on-year decrease of 25.30% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 17.8941 million yuan, down 31.03% year-on-year [1] - Basic earnings per share were reported at 0.07 yuan [1]

Group 1 - Huarong Chemical (SZ 301256, closing price: 11.61 yuan) announced on August 12 that its second session of the 13th board meeting was held on August 12, 2025, combining on-site and remote voting methods [2] - For the year 2024, Huarong Chemical's revenue composition is as follows: chemical product production and sales accounted for 71.24%, supply chain management business accounted for 27.94%, and other businesses accounted for 0.82% [2]